Inify Laboratories Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Inify Laboratories
Access all reports
Inify Laboratories specializes in cancer diagnostics, focusing primarily on pathology services. Leveraging advanced technology, the company employs a fully digital, standardized, and AI-supported workflow designed to enhance both the quality and efficiency of diagnostic processes, initially targeting prostate cancer diagnostics. This comprehensive service encompasses the entire sample handling process, including logistics, preparation, and reporting. The company is headquartered in Solna, Sweden, and its shares are listed on the Oslo Stock Exchange.
Latest articles
The Samsung Co-CEOs: Jong-Hee Han & Young-Hyun Jun
Samsung Electronics' dual-CEO structure, led by Jong-Hee Han and Young-Hyun Jun, is designed to navigate the complexities of its diverse business.
3 Oct 2024
Irwin Jacobs & Andrew Viterbi: Qualcomm's Pioneering Founders
In 1985, Irwin Jacobs and Andrew Viterbi co-founded Qualcomm, a leading company in telecommunications and semiconductor innovation.
3 Oct 2024
AMD: Shaping the Future of Semiconductor Processors
With a background in the U.S. semiconductor evolution, AMD has grown into a powerful player in producing high-quality, competitive processors.
1 Oct 2024
Ticker symbol
INIFY
Country
🇳🇴 Norway